Screening of New Markers of Gut Microbiota in Stroke and Depression: a Cross-sectional Study

NCT06379464 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2024-04-23

No results posted yet for this study

Summary

Objectives of Study: Through the cross-sectional study of stroke and depression, key biomarkers are targeted by screening disease-associated intestinal bacteria, metabolites and immune factors through multi-omics techniques.

Conditions

Sponsors & Collaborators

  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • Hongwei Zhou · Zhujiang Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-06-30
Completion
2024-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06379464 on ClinicalTrials.gov